Taking aim at disease

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus
ORNL radioisotope manufacturing coordinator Jillene Sennon-Greene places a shipment vial of actinium-225 inside the dose calibrator to confirm its activity is within customer specifications. (Photo: Carlos Jones/ORNL, DOE)

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

To continue reading, log in or create a free account!

Related Articles

Nuclear connections

February 13, 2025, 12:01PMNuclear News

As I watched the coverage of former U.S. president Jimmy Carter’s earthly farewell, I reflected on being too young to remember his presidency yet being impacted many years later. A man of...

An open letter to Chris Wright

February 6, 2025, 3:05PMNuclear News

Dear Secretary Wright:On behalf of the U.S. nuclear professional community, I offer our sincere congratulations to you on your becoming the secretary of energy.By now, I’m sure you have...